Echeverry‐Quiceno, L. M., Llambrich, S., Heredia‐Lidón, Á., Giménez, S., Rozalem‐Aranha, M., Inampudi, P., Heuzé, Y., Sevillano, X., Fortea, J., & Martínez‐Abadías, N. (2025). Potential of facial biomarkers for Alzheimer’s disease and obstructive sleep apnea in Down syndrome and general population. The FASEB Journal, 39(6). Portico. https://doi.org/10.1096/fj.202403009r

Bateman, R. J., Li, Y., McDade, E. M., Llibre-Guerra, J. J., Clifford, D. B., Atri, A., Mills, S. L., Santacruz, A. M., Wang, G., Supnet, C., Benzinger, T. L. S., Gordon, B. A., Ibanez, L., Klein, G., Baudler, M., Doody, R. S., Delmar, P., Kerchner, G. A., Bittner, T., … Schofield, P. R. (2025). Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. The Lancet Neurology, 24(4), 316–330. https://doi.org/10.1016/s1474-4422(25)00024-9

Zhao, J., Gu, T., Gao, C., Miao, G., Palma-Gudiel, H., Yu, L., Yang, J., Wang, Y., Li, Y., Lim, J., Li, R., Yao, B., Wu, H., Schneider, J. A., Seyfried, N., Grodstein, F., De Jager, P. L., Jin, P., & Bennett, D. A. (2025). Brain 5-hydroxymethylcytosine alterations are associated with Alzheimer’s disease neuropathology. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-58159-w

Fioriti, L., Wijesekara, N., Argyrousi, E. K., Matsuzaki, S., Takamura, H., Satoh, K., Han, K., Yamauchi, H., Staniszewski, A., Acquarone, E., Orsini, F., Martucci, A., Katayama, T., Arancio, O., & Fraser, P. E. (2025). Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer’s disease. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.70030

Reho, P., Kalia, V., Jackson, G. L., Wang, F., Eiten, E., Brennan, K., Brickman, A. M., Mayeux, R., Miller, G. W., Vardarajan, B. N., Baccarelli, A., & Wu, H. (2025). Preclinical Alzheimer’s disease shows alterations in circulating neuronal‐derived extracellular vesicle microRNAs in a multiethnic cohort. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.70050

Vialle, R. A., de Paiva Lopes, K., Li, Y., Ng, B., Schneider, J. A., Buchman, A. S., Wang, Y., Farfel, J. M., Barnes, L. L., Wingo, A. P., Wingo, T. S., Seyfried, N. T., De Jager, P. L., Gaiteri, C., Tasaki, S., & Bennett, D. A. (2025). Structural variants linked to Alzheimer’s disease and other common age-related clinical and neuropathologic traits. Genome Medicine, 17(1). https://doi.org/10.1186/s13073-025-01444-6

Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., La Joie, R., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Moscoso Rial, A., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. (2025). Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.14528

Arnold, M., Buyukozkan, M., Doraiswamy, P. M., Nho, K., Wu, T., Gudnason, V., Launer, L. J., Wang-Sattler, R., Adamski, J., De Jager, P. L., Ertekin-Taner, N., Bennett, D. A., Saykin, A. J., Peters, A., Suhre, K., Kaddurah-Daouk, R., Kastenmüller, G., & Krumsiek, J. (2025). Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-57032-0

Dong, S., Braun, D., Wu, X., Yitshak-Sade, M., Blacker, D., Kioumourtzoglou, M.-A., Schwartz, J., Mork, D., Dominici, F., & Zanobetti, A. (2025). The impacts of air pollution on mortality and hospital readmission among Medicare beneficiaries with Alzheimer’s disease and Alzheimer’s disease-related dementias: a national retrospective cohort study in the USA. The Lancet Planetary Health, 9(2), e114–e123. https://doi.org/10.1016/s2542-5196(25)00001-4

Katsumi, Y., Touroutoglou, A., Brickhouse, M., Eloyan, A., Eckbo, R., Zaitsev, A., La Joie, R., Lagarde, J., Schonhaut, D., Thangarajah, M., Taurone, A., Vemuri, P., Jack, C. R., Dage, J. L., Nudelman, K. N. H., Foroud, T., Hammers, D. B., Ghetti, B., … Murray, M. E. (2025). Dissociable spatial topography of cortical atrophy in early‐onset and late‐onset Alzheimer’s disease: A head‐to‐head comparison of the LEADS and ADNI cohorts. Alzheimer’s & Dementia, 21(2). Portico. https://doi.org/10.1002/alz.14489

Putcha, D., Katsumi, Y., Touroutoglou, A., Eloyan, A., Taurone, A., Thangarajah, M., Aisen, P., Dage, J. L., Foroud, T., Jack, C. R., Kramer, J. H., Nudelman, K. N. H., Raman, R., Vemuri, P., Atri, A., Day, G. S., Duara, R., Graff-Radford, N. R., Grant, I. M., … Honig, L. S. (2025). Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-025-01689-8

Mielke, M. M., Evans, J. K., Neiberg, R. H., Molina-Henry, D. P., Marcovina, S. M., Johnson, K. C., Carmichael, O. T., Rapp, S. R., Sachs, B. C., Ding, J., Shappell, H. M., Luchsinger, J. A., Espeland, M. A., & Hayden, K. M. (2025). Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity. JAMA Network Open, 8(2), e2458149. https://doi.org/10.1001/jamanetworkopen.2024.58149

Guo, M. H., Lee, W.-P., Vardarajan, B., Schellenberg, G. D., & Phillips-Cremins, J. E. (2025). Polygenic burden of short tandem repeat expansions promotes risk for Alzheimer’s disease. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-56400-0

Elyaman, W., Stern, L. J., Jiang, N., Dressman, D., Bradley, P., Klatzmann, D., Bradshaw, E. M., Farber, D. L., Kent, S. C., Chizari, S., Funk, K., Devanand, D., Thakur, K. T., Raj, T., Dalahmah, O. A., Sarkis, R. A., Weiner, H. L., Shneider, N. A., & Przedborski, S. (2025). Exploring the role of T cells in Alzheimer’s and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14548

Pandey, N., Yang, Z., Cieza, B., Reyes-Dumeyer, D., Kang, M. S., Montesinos, R., Soto-Añari, M., Custodio, N., Honig, L. S., & Tosto, G. (2025). Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-024-01655-w

Siemers, E., Feaster, T., Sethuraman, G., Sundell, K., Skljarevski, V., Cline, E. N., Zhang, H., Jerecic, J., Honig, L. S., Salloway, S., Sperling, R., Trame, M. N., Dodds, M. G., & Johnson, K. (2025). INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The Journal of Prevention of Alzheimer’s Disease, 12(1), 100005. https://doi.org/10.1016/j.tjpad.2024.100005

Hammers, D. B., Eloyan, A., Thangarajah, M., Taurone, A., Beckett, L., Gao, S., Polsinelli, A. J., Kirby, K., Dage, J. L., Nudelman, K., Aisen, P., Reman, R., La Joie, R., Lagarde, J., Atri, A., Clark, D., Day, G. S., Duara, R., … Graff‐Radford, N. R. (2024). Differences in baseline cognitive performance between participants with early‐onset and late‐onset Alzheimer’s disease: Comparison of LEADS and ADNI. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14218

Hammers, D. B., Eloyan, A., Taurone, A., Thangarajah, M., Gao, S., Beckett, L., Polsinelli, A. J., Kirby, K., Dage, J. L., Nudelman, K., Aisen, P., Reman, R., La Joie, R., Lagarde, J., Atri, A., Clark, D., Day, G. S., Duara, R., … Graff‐Radford, N. R. (2024). Longitudinal cognitive performance of participants with sporadic early onset Alzheimer’s disease from LEADS. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14439

Wu, Y., Libby, J. B., Dumitrescu, L., De Jager, P. L., Menon, V., Schneider, J. A., Bennett, D. A., & Hohman, T. J. (2024). Association of ten VEGF family genes with Alzheimer’s disease endophenotypes at single cell resolution. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14419

Yao, M., Miller, G. W., Vardarajan, B. N., Baccarelli, A. A., Guo, Z., & Liu, Z. (2024). Deciphering proteins in Alzheimer’s disease: A new Mendelian randomization method integrated with AlphaFold3 for 3D structure prediction. Cell Genomics, 4(12), 100700. https://doi.org/10.1016/j.xgen.2024.100700

Roy, N., Haq, I., Ngo, J. C., Bennett, D. A., Teich, A. F., De Jager, P. L., Olah, M., & Sher, F. (2024). Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02835-6

Fowler, S. L., Behr, T. S., Turkes, E., O’Brien, D. P., Cauhy, P. M., Rawlinson, I., Edmonds, M., Foiani, M. S., Schaler, A., Crowley, G., Bez, S., Ficulle, E., Tsefou, E., Fischer, R., Geary, B., Gaur, P., Miller, C., D’Acunzo, P., Levy, E., … Ryskeldi-Falcon, B. (2024). Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease. Nature Neuroscience. https://doi.org/10.1038/s41593-024-01801-5

Vockert, N., Machts, J., Kleineidam, L., Nemali, A., Incesoy, E. I., Bernal, J., Schütze, H., Yakupov, R., Peters, O., Gref, D., Schneider, L. S., Preis, L., Priller, J., Spruth, E. J., Altenstein, S., Schneider, A., Fliessbach, K., Wiltfang, J., … Rostamzadeh, A. (2024). Cognitive reserve against Alzheimer’s pathology is linked to brain activity during memory formation. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-53360-9

Boerwinkle, A. H., Wisch, J. K., Handen, B. L., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S. E., Krinsky‐McHale, S. J., Lai, F., Rosas, H. D., Zaman, S., Lott, I. T., Tudorascu, D., Zammit, M., Brickman, A. M., Lee, J. H., & Ances, B. M. (2024). The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down’s syndrome. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14359

Seifar, F., Fox, E. J., Shantaraman, A., Liu, Y., Dammer, E. B., Modeste, E., Duong, D. M., Yin, L., Trautwig, A. N., Guo, Q., Xu, K., Ping, L., Reddy, J. S., Allen, M., Quicksall, Z., Heath, L., Scanlan, J., Wang, E., Wang, M., … Seyfried, N. T. (2024). Large‐scale deep proteomic analysis in Alzheimer’s disease brain regions across race and ethnicity. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14360

Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024). Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias. Journal of Alzheimer’s Disease, 101(s1), S345–S356. https://doi.org/10.3233/jad-240495

Roberts, J. A., Varma, V. R., Jones, A., & Thambisetty, M. (2024). Drug Repurposing for Effective Alzheimer’s Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches. Journal of Alzheimer’s Disease, 101(s1), S299–S315. https://doi.org/10.3233/jad-240680

Jones, A. A., Ramos‐Miguel, A., Gicas, K. M., Petyuk, V. A., Leurgans, S. E., De Jager, P. L., Schneider, J. A., Bennett, D. A., Honer, W. G., & Casaletto, K. B. (2024). A multilayer network analysis of Alzheimer’s disease pathogenesis: Roles for p‐tau, synaptic peptides, and physical activity. Alzheimer’s & Dementia, 20(11), 8012–8027. Portico. https://doi.org/10.1002/alz.14286

Carmona-Iragui, M., O’Connor, A., Llibre-Guerra, J., Lao, P., Ashton, N. J., Fortea, J., & Sánchez-Valle, R. (2024). Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer’s disease and Down syndrome. EBioMedicine, 108, 105327. https://doi.org/10.1016/j.ebiom.2024.105327

Tahmi, M., Rippon, B., Palta, P., Sherwood, G., Hernandez, G., Soto, L., Cespedes, S., Pardo, M., Laing, K., Igwe, K., Johnson, A., Tomljanovic, Z., He, H., Gutierrez, J., Teresi, J. A., Moreno, H., Kreisl, W., Razlighi, Q., Brickman, A. M., & Luchsinger, J. A. (2024). Relationship Between Alzheimer Disease Imaging Biomarkers and Performance on the NIH Toolbox Cognition Battery in Late-middle Age Hispanics. Alzheimer Disease & Associated Disorders, 38(4), 311–318. https://doi.org/10.1097/wad.0000000000000641

Jin, M., & Noble, J. M. (2024). What’s in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer’s Disease. Eneuro, 11(9), ENEURO.0088-24.2024. https://doi.org/10.1523/eneuro.0088-24.2024

Sewell, K. R., Doecke, J. D., Xiong, C., Benzinger, T., Masters, C. L., Laske, C., Jucker, M., Lopera, F., Gordon, B. A., Llibre‐Guerra, J., Levin, J., Huey, E. D., Hassenstab, J., Schofield, P. R., Day, G. S., Fox, N. C., Chhatwal, J., Ibanez, L., … Roh, J. H. (2024). Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia, 20(11), 7923–7939. Portico. https://doi.org/10.1002/alz.14270

Hojjati, S. H., Butler, T. A., Luchsinger, J. A., Benitez, R., de Leon, M., Nayak, S., Razlighi, Q. R., & Chiang, G. C. (2024). Increased between-network connectivity: A risk factor for tau elevation and disease progression. Neuroscience Letters, 840, 137943. https://doi.org/10.1016/j.neulet.2024.137943

Burke, M. R., Sotiropoulos, I., & Waites, C. L. (2024). The multiple roles of chronic stress and glucocorticoids in Alzheimer’s disease pathogenesis. Trends in Neurosciences, 47(11), 933–948. https://doi.org/10.1016/j.tins.2024.08.015

Nho, K., Risacher, S. L., Apostolova, L. G., Bice, P. J., Brosch, J. R., Deardorff, R., Faber, K., Farlow, M. R., Foroud, T., Gao, S., Rosewood, T., Kim, J. P., Nudelman, K., Yu, M., Aisen, P., Sperling, R., Hooli, B., Shcherbinin, S., Svaldi, D., … Saykin, A. J. (2024). CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-52298-2

Beckers, L., Rashid, M., Lee, A. J., Chatila, Z. K., Tamucci, K. A., Talcoff, R. C., Hall, J. L., Bennett, D. A., Vardarajan, B. N., & Bradshaw, E. M. (2024). CD33 and SHP-1/PTPN6 Interaction in Alzheimer’s Disease. Genes, 15(9), 1204. https://doi.org/10.3390/genes15091204

Bathini, P., Brai, E., Balin, B. J., Bimler, L., Corry, D. B., Devanand, D. P., Doty, R. L., Ehrlich, G. D., Eimer, W. A., Fulop, T., Hahn, D. L., Hammond, C. J., Infanti, J., Itzhaki, R., Lathe, R., Little, C. S., McLeod, R., Moein, S. T., Nelson, A. R., … Alberi Auber, L. (2024). Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer’s Disease. The Journal of Infectious Diseases, 230(Supplement_2), S150–S164. https://doi.org/10.1093/infdis/jiae328

Lennon, M. J., Lipnicki, D. M., Lam, B. C. P., Crawford, J. D., Schutte, A. E., Peters, R., Rydberg-Sterner, T., Najar, J., Skoog, I., Riedel-Heller, S. G., Röhr, S., Pabst, A., Lobo, A., De-la-Cámara, C., Lobo, E., Lipton, R. B., Katz, M. J., Derby, C. A., … Kim, K. W. (2024). Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk. Neurology, 103(5). https://doi.org/10.1212/wnl.0000000000209715

Gunasekaran, T. I., Reyes‐Dumeyer, D., Faber, K. M., Goate, A., Boeve, B., Cruchaga, C., Pericak‐Vance, M., Haines, J. L., Rosenberg, R., Tsuang, D., Mejia, D. R., Medrano, M., Lantigua, R. A., Sweet, R. A., Bennett, D. A., Wilson, R. S., Alba, C., Dalgard, C., Foroud, T., … Mayeux, R. (2024). Missense and loss‐of‐function variants at GWAS loci in familial Alzheimer’s disease. Alzheimer’s & Dementia, 20(11), 7580–7594. Portico. https://doi.org/10.1002/alz.14221

Green, G. S., Fujita, M., Yang, H.-S., Taga, M., Cain, A., McCabe, C., Comandante-Lou, N., White, C. C., Schmidtner, A. K., Zeng, L., Sigalov, A., Wang, Y., Regev, A., Klein, H.-U., Menon, V., Bennett, D. A., Habib, N., & De Jager, P. L. (2024). Cellular communities reveal trajectories of brain ageing and Alzheimer’s disease. Nature, 633(8030), 634–645. https://doi.org/10.1038/s41586-024-07871-6

Perreira, K. M., Hotz, V. J., Duke, N. N., Aiello, A. E., Belsky, D. W., Brown, T., Jensen, T., & Harris, K. M. (2024). The Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias. Journal of Alzheimer’s Disease, 101(2), 681–691. https://doi.org/10.3233/jad-240201

Chen, Q., Aguirre, L., Liang, G., Zhao, H., Dong, T., Borrego, F., de Rojas, I., Hu, Q., Reyes, C., Su, L.-Y., Zhang, B., Lechleiter, J. D., Göring, H. H. H., De Jager, P. L., Kleinman, J. E., Hyde, T. M., Li, P. P., Ruiz, A., Weinberger, D. R., … Ma, L. (2024). Identification of a specific APOE transcript and functional elements associated with Alzheimer’s disease. Molecular Neurodegeneration, 19(1). https://doi.org/10.1186/s13024-024-00751-7

L’Esperance, O. J., McGhee, J., Davidson, G., Niraula, S., Smith, A. S., Sosunov, A. A., Yan, S. S., & Subramanian, J. (2024). Functional Connectivity Favors Aberrant Visual Network c-Fos Expression Accompanied by Cortical Synapse Loss in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 101(1), 111–131. https://doi.org/10.3233/jad-240776

Ma, Y., Reyes-Dumeyer, D., Piriz, A., Recio, P., Mejia, D. R., Medrano, M., Lantigua, R. A., Vonsattel, J. P. G., Tosto, G., Teich, A. F., Ciener, B., Leskinen, S., Sivakumar, S., DeTure, M., Ranjan, D., Dickson, D., Murray, M., Lee, E., Wolk, D. A., … Vardarajan, B. N. (2024). Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02778-y

Chen, S., Cao, Z., Nandi, A., Counts, N., Jiao, L., Prettner, K., Kuhn, M., Seligman, B., Tortorice, D., Vigo, D., Wang, C., & Bloom, D. E. (2024). The global macroeconomic burden of Alzheimer’s disease and other dementias: estimates and projections for 152 countries or territories. The Lancet Global Health, 12(9), e1534–e1543. https://doi.org/10.1016/s2214-109x(24)00264-x

Bae, S., Liu, K., Pouliopoulos, A. N., Ji, R., Jiménez-Gambín, S., Yousefian, O., Kline-Schoder, A. R., Batts, A. J., Tsitsos, F. N., Kokossis, D., Mintz, A., Honig, L. S., & Konofagou, E. E. (2024). Transcranial blood-brain barrier opening in Alzheimer’s disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping. Theranostics, 14(11), 4519–4535. https://doi.org/10.7150/thno.94206

Parrish, R. L., Buchman, A. S., Tasaki, S., Wang, Y., Avey, D., Xu, J., De Jager, P. L., Bennett, D. A., Epstein, M. P., & Yang, J. (2024). SR-TWAS: leveraging multiple reference panels to improve transcriptome-wide association study power by ensemble machine learning. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50983-w

Tayran, H., Yilmaz, E., Bhattarai, P., Min, Y., Wang, X., Ma, Y., Wang, N., Jeong, I., Nelson, N., Kassara, N., Cosacak, M. I., Dogru, R. M., Reyes-Dumeyer, D., Stenersen, J. M., Reddy, J. S., Qiao, M., Flaherty, D., Gunasekaran, T. I., Yang, Z., … Kizil, C. (2024). ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling. Cell Genomics, 4(9), 100642. https://doi.org/10.1016/j.xgen.2024.100642

Ribeiro, F. C., Cozachenco, D., Argyrousi, E. K., Staniszewski, A., Wiebe, S., Calixtro, J. D., Soares‐Neto, R., Al‐Chami, A., Sayegh, F. E., Bermudez, S., Arsenault, E., Cossenza, M., Lacaille, J., Nader, K., Sun, H., De Felice, F. G., Lourenco, M. V., Arancio, O., Aguilar‐Valles, A., … Ferreira, S. T. (2024). The ketamine metabolite (2R,6R)‐hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer’s disease. Alzheimer’s & Dementia, 20(8), 5398–5410. Portico. https://doi.org/10.1002/alz.14034

Kharaghani, A., Tio, E. S., Milic, M., Bennett, D. A., De Jager, P. L., Schneider, J. A., Sun, L., & Felsky, D. (2024). Association of whole-person eigen-polygenic risk scores with Alzheimer’s disease. Human Molecular Genetics, 33(15), 1315–1327. https://doi.org/10.1093/hmg/ddae067